½ÃÀ庸°í¼­
»óǰÄÚµå
1529870

±ÙÀ° Àڱر⠽ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¸ð´Þ¸®Æ¼º°, Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

Muscle Stimulator Market Size, Share & Trends Analysis Report By Modality (Handheld, Portable, Table Top), By Product, By Application (Pain Management, Musculoskeletal Disorder), By End-use, By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 130 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

±ÙÀ° Àڱر⠽ÃÀå ¼ºÀå ¹× µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è ±ÙÀ° Àڱر⠽ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2030³â±îÁö 3.3%ÀÇ CAGRÀ» ±â·ÏÇÏ¿© 2030³â¿¡´Â 9¾ï 9,730¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

»ê¾÷ ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀº Àü ¼¼°èÀûÀ¸·Î ±Ù°ñ°Ý°è ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ½ºÆ÷Ã÷ ÀÇÇп¡¼­ ÅëÁõ °ü¸® ¿ä¹ý¿¡ ´ëÇÑ Á߿伺ÀÌ ³ô¾ÆÁø °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ¹°¸®Ä¡·á»çµéÀÌ ¼ö±â Ä¡·á¿¡¼­ ±â¼úÀûÀ¸·Î Áøº¸µÈ ±â¼ú·Î ÀüȯÇÔ¿¡ µû¶ó ¹°¸®Ä¡·á»çµé »çÀÌ¿¡¼­ ±ÙÀ° ÀڱرâÀÇ ÀαⰡ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

È£ÈíºÎÀü ȯÀÚÀÇ ÀΰøÈ£Èí±â ÀÌÅ»À» µ½±â À§ÇØ ½Å°æ±Ù Àü±â Àڱر⠻ç¿ëÀ» Á¶»çÇÏ´Â ¹«ÀÛÀ§, À§¾à ´ëÁ¶, ¸Í°Ë ½ÃÇèÀÎ Liberate MedicalÀÇ PREVENT ½ÃÇèÀÇ È¯ÀÚ µî·Ï ½ÃÀÛÀº ±ÙÀ° Àڱر⠽ÃÀå¿¡ Áß¿äÇÑ Àǹ̸¦ °®½À´Ï´Ù. ÀÇ·á ±â¼ú ±â¾÷ ¸®¹ö·¹ÀÌÆ® ¸ÞµðÄÃ(Liberate Medical)ÀÌ PREVENT(Á¶±â ½Å°æ±Ù Àü±â ÀÚ±ØÀ» ÅëÇÑ È£ÈíºÎÀü ÁøÇà ¿¹¹æ) ÀÓ»ó½ÃÇèÀÇ È¯ÀÚ µî·ÏÀ» ½ÃÀÛÇß½À´Ï´Ù. PREVENT ¿¬±¸´Â ¹Ì±¹ ±¹¹æºÎ(DOD)ÀÇ Peer Reviewed Medical Research Programme(Peer Reviewed Medical Research Programme)ÀÇ Áö¿øÀ» ¹Þ¾Æ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. DOD´Â ÀÌ Á¶»ç ÇÁ·ÎÁ§Æ®¸¦ À§ÇØ ¸®¹ö·¹ÀÌÆ® ¸ÞµðÄÿ¡ 680¸¸ ´Þ·¯¸¦ Áö¿øÇß½À´Ï´Ù.

¿þ¾î·¯ºí ±ÙÀ° Àڱرâ¿Í °°Àº ÀÇ·á Á¦Ç°ÀÇ ±â¼ú ¹ßÀüµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹«¼±À¸·Î ÈÞ´ëÇÒ ¼ö ÀÖ´Â ±ÙÀ° Àڱر⿡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ½º¸¶Æ®Æù°úÀÇ È£È¯¼ºÀÌ ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ±ÙÀ° ÀÚ±Ø Ä¡·á°¡ ÇÊ¿äÇÑ ½ºÆ÷Ã÷ ¼±¼öµé »çÀÌ¿¡¼­ Àü¹æ½ÊÀÚÀδë(ACL) ÆÄ¿­, °í°üÀý ±¼°î±Ù ±äÀå, ÇܽºÆ®¸µ ±äÀåÀÌ Áõ°¡Çϸ鼭 ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±ÙÀ° Àڱر⠽ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • Á¦Ç°º°·Î´Â °üÀý¿° À¯º´·ü Áõ°¡¿Í ½ºÆ÷Ã÷ ºÎ»ó ¹ß»ý·ü Áõ°¡·Î ÀÎÇØ °æÇÇÀû Àü±â ½Å°æ ÀÚ±Ø(TENS) ºÎ¹®ÀÌ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • ¸ð´Þ¸®Æ¼º°·Î´Â ÈÞ´ë¿ë ±â±â ºÎ¹®ÀÌ 2023³â ½ÃÀåÀ» Àå¾ÇÇϰí ÃßÁ¤ ¹× ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ¿ëµµº°·Î´Â ÅëÁõ °ü¸® ºÎ¹®ÀÌ 2023³â 54.2%ÀÇ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ¸ç ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °í·ÉÈ­´Â ÅëÁõ °ü¸® ºÎ¹®ÀÇ Áß¿äÇÑ ÃËÁøÁ¦ÀÔ´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµº°·Î´Â ¹°¸®Ä¡·á Ŭ¸®´Ð ºÐ¾ß°¡ 2023³â °¡Àå Å« ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇÏ°í ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • 2023³â ºÏ¹Ì°¡ 41.9%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÁÖ¿ä ÁøÀÔ ±â¾÷ÀÇ Á¸Àç, Á¤ºÎÀÇ ´ë±Ô¸ð ÅõÀÚ. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼÷·ÃµÈ Àü¹®°¡ÀÇ °¡¿ë¼º°ú ½ÅÈï ½ÃÀåÀÇ Á¸Àç´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ±ÙÀ° Àڱر⠽ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óºÎ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ±ÙÀ° Àڱر⠽ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ±ÙÀ° Àڱر⠽ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ±ÙÀ° Àڱر⠽ÃÀå : Á¦Ç°º° º¯µ¿ ºÐ¼®
  • ±ÙÀ° Àڱر⠽ÃÀå Á¦Ç°º° Àü¸Á
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • ½Å°æ±Ù Àü±â ÀÚ±Ø
  • ±â´ÉÀû Àü±â ÀÚ±Ø
  • °æÇÇÀû Àü±â ½Å°æÀÚ±Ø
  • °£¼·
  • ¹ö½ºÆ® ¸ðµå ±³·ù
  • ¸¶ÀÌÅ©·Î Àü·ù EMS
  • ±âŸ

Á¦5Àå ±ÙÀ° Àڱر⠽ÃÀå : ¸ð´Þ¸®Æ¼º° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ±ÙÀ° Àڱر⠽ÃÀå : ¸ð´Þ¸®Æ¼º° º¯µ¿ ºÐ¼®
  • ±ÙÀ° Àڱر⠽ÃÀå ¸ð´Þ¸®Æ¼º° Àü¸Á
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • ÇÚµåÇïµå
  • ÈÞ´ë¿ë
  • Å×À̺íÅé

Á¦6Àå ±ÙÀ° Àڱر⠽ÃÀå : ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ±ÙÀ° Àڱر⠽ÃÀå : ¿ëµµº° º¯µ¿ ºÐ¼®
  • ±ÙÀ° Àڱر⠽ÃÀå ¿ëµµº° Àü¸Á
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • ÅëÁõ °ü¸®
  • ½Å°æÁúȯ
  • ±Ù°ñ°Ý Àå¾Ö
  • ±âŸ

Á¦7Àå ±ÙÀ° Àڱر⠽ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ±ÙÀ° Àڱر⠽ÃÀå : ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®
  • ±ÙÀ° Àڱر⠽ÃÀå ÃÖÁ¾ ¿ëµµº° Àü¸Á
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ¹°¸®Ä¡·á Ŭ¸®´Ð
  • ½ºÆ÷Ã÷ Ŭ¸®´Ð
  • ȨÄɾî

Á¦8Àå ±ÙÀ° Àڱر⠽ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ª ´ë½Ãº¸µå
  • ±ÙÀ° Àڱر⠽ÃÀå : Áö¿ªº° º¯µ¿ ºÐ¼®
  • ±ÙÀ° Àڱر⠽ÃÀå : ±â¼ú°ú ÃÖÁ¾ ¿ëµµº° Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • ºÏ¹Ì
    • ºÏ¹ÌÀÇ ±ÙÀ° Àڱر⠽ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • À¯·´ÀÇ ±ÙÀ° Àڱر⠽ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±ÙÀ° Àڱر⠽ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ±ÙÀ° Àڱر⠽ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ±ÙÀ° Àڱر⠽ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦9Àå °æÀï »óȲ

  • ½ÃÀå ÁøÃâ ±â¾÷ ºÐ·ù
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • DJO Global, Inc.
    • Zynex, Inc.
    • NeuroMetrix, Inc.
    • RS Medical, Inc.
    • OMRON Corporation
    • Zimmer MedizinSysteme GmbH
    • BioMedical Life Systems, Inc.
    • EMS Physio Ltd.
    • Beurer GmbH
    • OG Wellness Technologies Co., Ltd.
ksm 24.08.29

Muscle Stimulator Market Growth & Trends:

The global muscle stimulator market size is expected to reach USD 997.3 million by 2030, exhibiting a CAGR of 3.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The major factors attributing the industry growth is rising emphasis on pain management therapies in sports medicine along with increasing prevalence of musculoskeletal disorders throughout the world. Moreover, increasing popularity of muscle stimulators among physiotherapists as they are shifting from manual techniques to technological advanced techniques, further fuels the market growth.

The commencement of patient enrollment in Liberate Medical's PREVENT study, a randomized, sham-controlled, blinded trial investigating the use of its neuromuscular electrical stimulator to help respiratory failure patients wean off mechanical ventilation, is significant for the muscle stimulator market. Liberate Medical, a medical technology company, has initiated patient enrollment in the PREVENT (Preventing Respiratory Failure Progression through Early Neuromuscular Electrical Stimulation) trial. This study aims to evaluate the effectiveness of Liberate's neuromuscular electrical stimulator (NMES) in helping respiratory failure patients wean off mechanical ventilation. The PREVENT trial is financially supported by the US Department of Defense (DOD) through its Peer Reviewed Medical Research Programme. The DOD granted $6.8 million to Liberate Medical for this research project.

Technological advancements in medical products such as wearable muscle stimulator devices also contribute towards market growth. Furthermore, the increasing demand for wireless and portable muscle stimulators and their compatibility with smartphones is creating a positive impact towards market growth. Growing cases of anterior cruciate ligament (ACL) tear, hip flexor strain, and hamstring strain among sports players that require muscle stimulation therapy is further projected to drive the growth.

Muscle Stimulator Market Report Highlights:

  • Based on the product, transcutaneous electrical nerve stimulation (TENS) segment held the largest market share in 2023 due to the growing prevalence of arthritis and increasing incidence of sports injuries.
  • Based on the modality, portable devices segment dominated the market in 2023 and is estimated to witness the highest CAGR during the forecast period.
  • Based on the application, pain management segment dominated the market with 54.2% of the market share in 2023 and is anticipated to grow at the fastest CAGR over the forecast period. The aging population is a significant driver for the pain management segment.
  • Based on the end-use, physiotherapy clinics segment dominated the market with the largest revenue share in 2023 and is anticipated to witness the highest CAGR during the forecast period.
  • In 2023, North America dominated with a share of 41.9% revenue share in 2023. The presence of key participants, large investments by governments. Asia Pacific is expected to grow at a fastest CAGR during the forecast period. The availability of trained professionals and the presence of developing healthcare facilities are expected to drive market growth over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.1. Segment Definitions
    • 1.1.1. Product
    • 1.1.2. Modality
    • 1.1.3. Application
    • 1.1.4. End Use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Modality outlook
    • 2.2.3. Application outlook
    • 2.2.4. End Use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Muscle Stimulator Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Muscle Stimulator Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Muscle Stimulator Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Muscle Stimulator Market: Product Movement Analysis
  • 4.3. Muscle Stimulator Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Neuromuscular Electrical Stimulation
    • 4.5.1. Neuromuscular Electrical Stimulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Functional Electrical Stimulation
    • 4.6.1. Functional Electrical Stimulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Transcutaneous Electrical Nerve Stimulation
    • 4.7.1. Transcutaneous Electrical Nerve Stimulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Interferential
    • 4.8.1. Interferential Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Burst Mode Alternating Current
    • 4.9.1. Burst Mode Alternating Current Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.10. Micro Current EMS
    • 4.10.1. Micro Current EMS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.11. Others
    • 4.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Muscle Stimulator Market: Modality Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Muscle Stimulator Market: Modality Movement Analysis
  • 5.3. Muscle Stimulator Market by Modality Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Handheld
    • 5.5.1. Handheld Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Portable
    • 5.6.1. Portable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Tabletop
    • 5.7.1. Tabletop Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Muscle Stimulator Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Muscle Stimulator Market: Application Movement Analysis
  • 6.3. Muscle Stimulator Market by Application Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Pain Management
    • 6.5.1. Pain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Neurological Disorder
    • 6.6.1. Neurological Disorder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Musculoskeletal disorder
    • 6.7.1. Musculoskeletal Disorder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Muscle Stimulator Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Muscle Stimulator Market: End Use Movement Analysis
  • 7.3. Muscle Stimulator Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Hospitals
    • 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Ambulatory Surgical Centers
    • 7.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Physiotherapy Clinics
    • 7.7.1. Physiotherapy Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Sports Clinics
    • 7.8.1. Sports Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Home care
    • 7.9.1. Home care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Muscle Stimulator Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Regional Muscle Stimulator Market movement analysis
  • 8.3. Muscle Stimulator Market: Regional Estimates & Trend Analysis by Technology & End Use
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.5. North America
    • 8.5.1. North America Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. U.S.
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. U.S. Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Canada
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Canada Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. Mexico
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Mexico Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Europe
    • 8.6.6. Europe Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. UK
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. UK Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.8. Germany
      • 8.6.8.1. Key Country Dynamics
      • 8.6.8.2. Competitive Scenario
      • 8.6.8.3. Regulatory Framework
      • 8.6.8.4. Germany Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.9. France
      • 8.6.9.1. Key Country Dynamics
      • 8.6.9.2. Competitive Scenario
      • 8.6.9.3. Regulatory Framework
      • 8.6.9.4. France Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.10. Italy
      • 8.6.10.1. Key Country Dynamics
      • 8.6.10.2. Competitive Scenario
      • 8.6.10.3. Regulatory Framework
      • 8.6.10.4. Italy Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.11. Spain
      • 8.6.11.1. Key Country Dynamics
      • 8.6.11.2. Competitive Scenario
      • 8.6.11.3. Regulatory Framework
      • 8.6.11.4. Spain Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.12. Denmark
      • 8.6.12.1. Key Country Dynamics
      • 8.6.12.2. Competitive Scenario
      • 8.6.12.3. Regulatory Framework
      • 8.6.12.4. Denmark Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.13. Sweden
      • 8.6.13.1. Key Country Dynamics
      • 8.6.13.2. Competitive Scenario
      • 8.6.13.3. Regulatory Framework
      • 8.6.13.4. Sweden Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.14. Norway
      • 8.6.14.1. Key Country Dynamics
      • 8.6.14.2. Competitive Scenario
      • 8.6.14.3. Regulatory Framework
      • 8.6.14.4. Reimbursement scenario
      • 8.6.14.5. Norway Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Asia Pacific Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Japan
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Japan Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. China
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. China Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. India
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. India Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. South Korea Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.6. Australia
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Framework
      • 8.7.6.4. Australia Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.7. Thailand
      • 8.7.7.1. Key Country Dynamics
      • 8.7.7.2. Competitive Scenario
      • 8.7.7.3. Regulatory Framework
      • 8.7.7.4. Thailand Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Latin America Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. Brazil
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Brazil Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Argentina
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.9.3.4. Argentina Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9. Middle East & Africa
    • 8.9.1. Middle East & Africa Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.2. South Africa
      • 8.9.2.1. Key Country Dynamics
      • 8.9.2.2. Competitive Scenario
      • 8.9.2.3. Regulatory Framework
      • 8.9.2.4. South Africa Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.3. Saudi Arabia
      • 8.9.3.1. Key Country Dynamics
      • 8.9.3.2. Competitive Scenario
      • 8.9.3.3. Regulatory Framework
      • 8.9.3.4. Saudi Arabia Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.4. UAE
      • 8.9.4.1. Key Country Dynamics
      • 8.9.4.2. Competitive Scenario
      • 8.9.4.3. Regulatory Framework
      • 8.9.4.4. UAE Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.5. Kuwait
      • 8.9.5.1. Key Country Dynamics
      • 8.9.5.2. Competitive Scenario
      • 8.9.5.3. Regulatory Framework
      • 8.9.5.4. Kuwait Muscle Stimulator Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. DJO Global, Inc.
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Zynex, Inc.
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. NeuroMetrix, Inc.
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. RS Medical, Inc.
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. OMRON Corporation
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Zimmer MedizinSysteme GmbH
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. BioMedical Life Systems, Inc.
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. EMS Physio Ltd.
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Beurer GmbH
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. OG Wellness Technologies Co., Ltd.
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦